Two new assays are designed to monitor the progression of early type 1 diabetes by measuring the levels of islet cell autoantibodies in blood circulation.
Read More »Diabetes In Control
Issue 144 Item 14 Remarkable Improvement In Insulin Resistance with Amaryl® (gli
Increased adiponectin levels contribute to the improvement in insulin resistance seen when elderly people with type 2 diabetes take Amaryl® (glimepiride) .
Read More »Issue 144 Item 3 Protein Processing Problems May Contribute to Diabetes
Study of cells derived from identical twins indicates that diminished expression of an important chaperone protein may be involved in the development of type I diabetes.
Read More »Issue 144 Item 13 Rate of Diabetes is Three Times Greater in Cheboygan Michigan
Furthermore, national studies from the U.S. Health and Human Services state that among Cheboygan County adults, 1,820 have pre-diabetes.
Read More »Issue 144 Item 2 HRT Shown to Reduce Diabetes Rate in Some Women
HRT can reduce diabetes by 35% in women with heart disease.
Read More »Issue 144 Item 12 Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes
With a HbA1c of 6%, there is a 75% increased risk of microvascular complications of type 2 diabetes
Read More »Issue 144 Item 1 Diabetes Prevention Efforts Achieving Good Results
The frequency in the population now is approaching 8%, up from about 5% a decade ago.
Read More »Issue 144 Item 11 Beta-Cell Death Outpaces Replacement in Type 2 Diabetes
Approaches designed to arrest beta-cell apoptosis could be a “significant new development in the management of type 2 diabetes.
Read More »Issue 144 Item 10 Rosuvastatin Reduces LDL Cholesterol and Improves Lipid Profil
Rosuvastatin (Crestor; AstraZeneca) is more effective than atorvastatin (Lipitor; Pfizer, Inc.)
Read More »Issue 143 Item 5 Intensive Treatment at Onset of Diagnosis of Diabetes Improves
Primary care providers do not appear to manage diabetes diagnosed at screening as intensively as long-standing diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.